Position in ABBV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$2,701,355
+$363,990 QoQ
Shares Held
10,735
-0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.30%
of 13F equity value
Holder Rank
#1,723
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ProVise Management Group, LLC holds $49,564,821 across 10 Drug Manufacturers - General names. ABBV ranks #6 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NVS |
Novartis AG
|
134,100 | $21,016,152 | |
| 2 | GSK |
GSK plc
|
123,527 | $6,475,285 | |
| 3 | AMGN |
Amgen Inc
|
16,496 | $5,973,531 | |
| 4 | SNY |
Sanofi
|
120,829 | $5,154,565 | |
| 5 | PFE |
Pfizer Inc
|
145,537 | $3,504,530 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
10,735 | $2,701,355 | |
| 7 | LLY |
ELI LILLY & Co
|
1,561 | $1,872,310 | |
| 8 | JNJ |
Johnson & Johnson
|
6,573 | $1,669,344 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,701,355 | 10,735 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $2,337,365 | 10,747 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $2,488,027 | 10,889 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $2,404,774 | 10,386 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,918,568 | 10,336 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $2,218,188 | 10,587 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,198,682 | 12,373 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $3,230,377 | 16,358 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $2,918,584 | 17,016 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,172,182 | 17,420 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $3,032,607 | 19,569 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,925,749 | 19,628 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,869,749 | 21,300 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $3,402,230 | 21,348 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $4,025,705 | 24,910 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,663,798 | 27,299 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $4,241,613 | 27,694 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $5,160,123 | 31,831 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $8,336,984 | 61,573 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $6,920,507 | 64,156 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $8,410,152 | 74,664 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $8,328,935 | 76,963 | Shares | Sole | 2021-04-22 | |
| 2020-12-31 | $8,240,049 | 76,902 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $6,757,393 | 77,148 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $7,418,088 | 75,556 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $4,235,249 | 55,588 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||